WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 6701 Infant (under 12 months) mortality rate: 822
GDP / capita (US$): 1'5131 Child (under 5 years) mortality rate: 1462

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 16'460  15'995  15'540  15'095  14'660  11'608  8'811  6'823 
Births 683  672  662  651  640  538  419  336 
Surviving infants 634  623  612  601  589  487  374  294 
Pop. less than 5 years 2'932  2'874  2'804  2'744  2'685  2'172  1'663  1'278 
Pop. less than 15 years 7'530  7'343  7'148  6'972  6'792  5'429  4'163  3'110 
Female 15-49 years 3'801  3'687  3'579  3'468  3'363  2'642  1'959  1'539 

Number of reported case

(Click for retrospective incidence data for Burkina Faso)
Diphtheria 725 
Japanese encephalitis
Measles 7'362  860  2'511  54'118  395  6'074  9'804  13'713 
Mumps
Pertussis 13  68  171  351  713  3'888 
Polio* 15  18  145 
Rubella 677  97 
Rubella (CRS)
Tetanus (neonatal) 22  100 
Tetanus (total) 74  11  100  746 
Yellow fever 1'024 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Burkina Faso)
Vaccine year result method % card seen                                                
BCG 2009  97  DHS/MICS   83.1  97  99  99  99*  99*  80 
DTP1 2009  94  DHS/MICS   83.1  94  93  93  99*  99*  84 
DTP3 2009  90  DHS/MICS   83.1  90  91  91  99*  99*  57 
HepB_BD         
HepB3          90  99*  99*  99*  99* 
Hib3          90  99*  99*  99*  99* 
JapEnc         
MCV 2009  87  DHS/MICS   83.1  87  63  63  94  99*  59 
MCV2         
PCV1         
PCV3         
Pol3 2009  90  DHS/MICS   83.1  90  90  90  99*  99*  57 
Rota1         
Rota_last         
Rubella1         
TT2plus 2009  71  DHS/MICS   83.1  86  82  82  94  95 
PAB         
VAD1          99*  99*  99* 
YFV 2008  94  EPI   95.5  87  82  82  93  99*  56  65 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Burkina Faso)
BCG 96  99  99  99  99  81  95 
DTP1 94  93  93  93  97  97  92 
DTP3 90  91  91  92  93  45  66 
HepB3 90  91  91  92  93 
Hib3 90  91  91  92  93 
MCV 87  89  92  94  94  48  79 
PAB 88  88  85  85  79  57  55 
PCV3
Pol3 90  90  90  91  92  45  66 
Rota_last
YFV 87  82  82  93  91  40 

Number of districts in the country 63  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 89
From 80 to 89% 11
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 8, 12, 16 weeks; Yes
Measles 9 months; Yes
OPV birth; 8, 12, 16 weeks; Yes
Pneumo_conj Yes From June 2013
TT 1st contact pregnancy; +1 month; +1, +2, +3 years; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2006-2010  2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 63  63  63  63  63  55  55 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 63  63  63  63  63  55  55 
Nº districts with DTP3 coverage >=80% number 63  62  63  63  62  54  52 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  98  100  100  98  98  95 
Nº districts with measles (MCV1) coverage >=95% number 46  43  39  36  49     
% of districts with MCV1 coverage >=95% From 0 to 100% 73  68  62  57  78     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 39  32  33  30  21  23  17 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.